Challenging a ruling that it breached its continuous disclosure obligations, ANZ has argued on appeal that it did not need to inform the ASX of a bailout by the underwriters of a 2015 institutional share placement because the information didn’t go to the fundamental value of its shares.
A class action against ANZ and former subsidiary OnePath has been given the green light to “significantly expand” its case against the big four bank, over three years after the case was first filed.
A Perth-based forex trader that allegedly failed to return investors’ funds or any profits made on trading has taken no steps in the undefended class action, a court has heard.
A Kurdish refugee has lost his appeal seeking compensation for being kept in makeshift hotel detention centres for 14 months after a judge found the detention lacked “human decency” but was not unlawful.
The corporate regulator is seeking to stay proceedings brought by Clive Palmer challenging the lawfulness of a seven year-old compulsory examination being used in a criminal case against him, arguing the billionaire’s litigation is an abuse of process.
Dental aligner maker Invisalign has won an appeal of a decision rejecting its case accusing SmileDirectClub of misleading consumers, but the appeals court noted that the prospect of a new trial was “remote” after its competitor went under.
A judge has approved a settlement in a shareholder class action against livestock exporter Wellard that grants a 34 per cent cut for group members, saying that investors had agreed to the lawyers and funder receiving the “lion’s share”.
An appeals court has granted the Commonwealth’s bid to suppress material relating to its “conduct after capture” training in a discrimination case brought by a former ADF member, finding that a document is not in the public domain simply because it is available for inspection on the court file.
The Australian unit of drug giant Mylan has triumphed in a dispute with Australian Taxation Office, with a judge finding the ATO’s assessment for 2020 was “excessive” with respect to interest on loans to fund Mylan’s $1.2 billion acquisition of generic drug maker Alphapharm.
A judge has declined to set aside a travel ban against a former director of collapsed cryptocurrency platform Blockchain Global, noting that the company’s liquidators may have claims of up to $42.9 million against him.